Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
The muscarinic acetylcholine receptor agonist BuTAC mediates antipsychotic-like effects via the M4 subtype.
Neuropsychopharmacology. 2013 Dec;38(13):2717-26. doi: 10.1038/npp.2013.186. Epub 2013 Aug 2.
Neuropsychopharmacology. 2013.
PMID: 23907402
Free PMC article.
Characterization of PCS1055, a novel muscarinic M4 receptor antagonist.
Croy CH, Chan WY, Castetter AM, Watt ML, Quets AT, Felder CC.
Croy CH, et al. Among authors: quets at.
Eur J Pharmacol. 2016 Jul 5;782:70-6. doi: 10.1016/j.ejphar.2016.04.022. Epub 2016 Apr 13.
Eur J Pharmacol. 2016.
PMID: 27085897
Item in Clipboard
Characterization of the novel positive allosteric modulator, LY2119620, at the muscarinic M(2) and M(4) receptors.
Croy CH, Schober DA, Xiao H, Quets A, Christopoulos A, Felder CC.
Croy CH, et al.
Mol Pharmacol. 2014 Jul;86(1):106-15. doi: 10.1124/mol.114.091751. Epub 2014 May 7.
Mol Pharmacol. 2014.
PMID: 24807965
Item in Clipboard
Translational Pharmacology of the Metabotropic Glutamate 2 Receptor-Preferring Agonist LY2812223 in the Animal and Human Brain.
Felder CC, Schober DA, Tu Y, Quets A, Xiao H, Watt M, Siuda E, Nisenbaum E, Xiang C, Heinz B, Prieto L, McKinzie DL, Monn JA.
Felder CC, et al.
J Pharmacol Exp Ther. 2017 Apr;361(1):190-197. doi: 10.1124/jpet.116.237859. Epub 2017 Jan 30.
J Pharmacol Exp Ther. 2017.
PMID: 28138041
Item in Clipboard
N-(4-((2-(trifluoromethyl)-3-hydroxy-4-(isobutyryl)phenoxy)methyl)benzyl)-1-methyl-1H-imidazole-4-carboxamide (THIIC), a novel metabotropic glutamate 2 potentiator with potential anxiolytic/antidepressant properties: in vivo profiling suggests a link between behavioral and central nervous system neurochemical changes.
Fell MJ, Witkin JM, Falcone JF, Katner JS, Perry KW, Hart J, Rorick-Kehn L, Overshiner CD, Rasmussen K, Chaney SF, Benvenga MJ, Li X, Marlow DL, Thompson LK, Luecke SK, Wafford KA, Seidel WF, Edgar DM, Quets AT, Felder CC, Wang X, Heinz BA, Nikolayev A, Kuo MS, Mayhugh D, Khilevich A, Zhang D, Ebert PJ, Eckstein JA, Ackermann BL, Swanson SP, Catlow JT, Dean RA, Jackson K, Tauscher-Wisniewski S, Marek GJ, Schkeryantz JM, Svensson KA.
Fell MJ, et al. Among authors: quets at.
J Pharmacol Exp Ther. 2011 Jan;336(1):165-77. doi: 10.1124/jpet.110.172957. Epub 2010 Oct 14.
J Pharmacol Exp Ther. 2011.
PMID: 20947638
Item in Clipboard
Identification of the hepatitis B virus factor that inhibits expression of the beta interferon gene.
Whitten TM, Quets AT, Schloemer RH.
Whitten TM, et al. Among authors: quets at.
J Virol. 1991 Sep;65(9):4699-704. doi: 10.1128/JVI.65.9.4699-4704.1991.
J Virol. 1991.
PMID: 1870197
Free PMC article.
Item in Clipboard
An internal domain of the hepatitis B virus X antigen is necessary for transactivating activity.
Ritter SE, Whitten TM, Quets AT, Schloemer RH.
Ritter SE, et al. Among authors: quets at.
Virology. 1991 Jun;182(2):841-5. doi: 10.1016/0042-6822(91)90626-m.
Virology. 1991.
PMID: 2024502
Item in Clipboard
Cite
Cite